These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21621758)

  • 1. Theoretical study of 3-D molecular similarity and ligand binding modes of orthologous human and rat D2 dopamine receptors.
    Soriano-Ursúa MA; Ocampo-López JO; Ocampo-Mendoza K; Trujillo-Ferrara JG; Correa-Basurto J
    Comput Biol Med; 2011 Jul; 41(7):537-45. PubMed ID: 21621758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenosine A2A receptor and dopamine D3 receptor interactions: evidence of functional A2A/D3 heteromeric complexes.
    Torvinen M; Marcellino D; Canals M; Agnati LF; Lluis C; Franco R; Fuxe K
    Mol Pharmacol; 2005 Feb; 67(2):400-7. PubMed ID: 15539641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
    Yuzlenko O; Kieć-Kononowicz K
    J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studying the catechol binding cavity in comparative models of human dopamine D2 receptor.
    Sakhteman A; Lahtela-Kakkonen M; Poso A
    J Mol Graph Model; 2011 Feb; 29(5):685-92. PubMed ID: 21168353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes.
    Boeckler F; Lanig H; Gmeiner P
    J Med Chem; 2005 Feb; 48(3):694-709. PubMed ID: 15689154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells.
    Van Leeuwen DH; Eisenstein J; O'Malley K; MacKenzie RG
    Mol Pharmacol; 1995 Aug; 48(2):344-51. PubMed ID: 7651368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders.
    Ferré S; Ciruela F; Canals M; Marcellino D; Burgueno J; Casadó V; Hillion J; Torvinen M; Fanelli F; Benedetti Pd Pd; Goldberg SR; Bouvier M; Fuxe K; Agnati LF; Lluis C; Franco R; Woods A
    Parkinsonism Relat Disord; 2004 Jul; 10(5):265-71. PubMed ID: 15196504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular modeling and docking study on dopamine D2-like and serotonin 5-HT2A receptors.
    Duan X; Zhang M; Zhang X; Wang F; Lei M
    J Mol Graph Model; 2015 Apr; 57():143-55. PubMed ID: 25728902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CoMFA and CoMSIA investigations revealing novel insights into the binding modes of dopamine D3 receptor agonists.
    Boeckler F; Ohnmacht U; Lehmann T; Utz W; Hübner H; Gmeiner P
    J Med Chem; 2005 Apr; 48(7):2493-508. PubMed ID: 15801839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
    Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
    J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictions of binding for dopamine D2 receptor antagonists by the SIE method.
    Wang YT; Su ZY; Hsieh CH; Chen CL
    J Chem Inf Model; 2009 Oct; 49(10):2369-75. PubMed ID: 19769359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of binding residues between scorpion neurotoxins and D2 dopamine receptor: a computational docking study.
    Sudandiradoss C; George Priya Doss C; Rajasekaran R; Purohit R; Ramanathan K; Sethumadhavan R
    Comput Biol Med; 2008 Oct; 38(10):1056-67. PubMed ID: 18799158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-optimized homology models of D₁ and D₂ dopamine receptors: application for virtual screening.
    Kołaczkowski M; Bucki A; Feder M; Pawłowski M
    J Chem Inf Model; 2013 Mar; 53(3):638-48. PubMed ID: 23398329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
    Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
    Bissantz C; Bernard P; Hibert M; Rognan D
    Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
    Lan H; Durand CJ; Teeter MM; Neve KA
    Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of A2A adenosine receptors in platelets from patients affected by bipolar disorders under treatment with typical antipsychotics.
    Martini C; Tuscano D; Trincavelli ML; Cerrai E; Bianchi M; Ciapparelli A; Alessio L; Novelli L; Catena M; Lucacchini A; Cassano GB; Dell'Osso L
    J Psychiatr Res; 2006 Feb; 40(1):81-8. PubMed ID: 16431220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychosis pathways converge via D2high dopamine receptors.
    Seeman P; Schwarz J; Chen JF; Szechtman H; Perreault M; McKnight GS; Roder JC; Quirion R; Boksa P; Srivastava LK; Yanai K; Weinshenker D; Sumiyoshi T
    Synapse; 2006 Sep; 60(4):319-46. PubMed ID: 16786561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.